Iovance TIL Appeal Seen Luring Potential Buyers

Media Reports Say US Biotech Is In Active M&A Talks

 
• By Sten Stovall
  
US_Dollars_MandA
Iovance specializes in cell therapy focused on treating solid tumors • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip